Solar Foods (SFOODS) CMD 2024 summary

Strategic vision, market focus, and product innovation

• Five-year strategy centers on scaling hydrogen fermentation technology and commercializing Solein®, a sustainable, animal-free, allergen-free protein ingredient, with a primary go-to-market focus on the U.S. Health & Performance Nutrition sector.

• U.S. market entry is prioritized due to faster regulatory approval (GRAS status), high willingness to pay, and strong demand for sustainable, high-protein alternatives, with initial applications in ready-to-mix powders, protein bars, and ready-to-drink beverages.

• Solein® is positioned as a premium, sustainable protein with a nutritional profile comparable to whey, targeting price parity with whey protein isolate and offering unique taste and texture benefits.

• Customer feedback and partnerships, such as with Ajinomoto, validate product-market fit and support concept selling to accelerate adoption, with strong demand from major brands.

• Long-term vision includes global scaling, mainstream recognition, and technological leadership, with ambitions to nourish 10 billion people within planetary limits.

Technology, production scaling, and operational milestones

• Proprietary hydrogen fermentation enables protein production with minimal land, water, and greenhouse gas impact, leveraging renewable electricity and disconnecting food production from land and climate constraints.

• Factory 01 is operational, with capacity increasing from 160 to 230 tons by 2026 through productivity improvements and food safety certification.

• Factory 02 will be developed in modular phases, targeting 12.8 kilotons annual output by 2030, with phased CapEx totaling EUR 317 million and operational readiness in 2028.

• CapEx for Factory 02 phase 1 could be reduced to EUR 69 million through brownfield synergies, grants, and a 50/50 equity-debt split.

• Ongoing R&D leverages AI/ML, explores new organisms, and develops precision fermentation, with future applications in space and new protein products.

Financial guidance, business model, and targets

• Factory 02's phased ramp-up is expected to deliver strong unit economics, with EBITDA margins of 57%-72% and COGS per kilogram dropping below EUR 5 as scale increases.

• Revenue from Factory 02 is projected to reach EUR 96–109 million annually at full capacity, with company-level EBITDA exceeding EUR 100 million per year in the long term.

• Positive EBITDA is targeted by 2030, driven by higher pricing, new markets, improved productivity, and phased CapEx, with sufficient funding expected for scale-up and commercialization.

• Business model remains focused on B2B ingredient supply, with potential for technology licensing, M&A, and space-related business opportunities.

• Solein's market price is expected at $16–25/kg in 2025–2026 and $13–20/kg in 2027–2030 for the target segment, with financial guidance for 2025 to be published in February 2025.